Signaling pathways
-
BA2693 AcLys-PABC-VC-Aur0101Summary: AcLys-PABC-VC-Aur0101 is part of an antibody-coupled active molecule (anti-ADC). -
BA2694 Fmoc-Val-Cit-PAB-MMAESummary: Fmoc-Val-Cit-PAB-MMAE consists of (Fmoc-Val-Cit-PAB) and MMAE, a potent microtubule (tubulin) inhibitor. -
BA2695 MP-PEG4-Val-Lys-Gly-7-MAD-MDCPTSummary: MP-PEG4-Val-Lys-Gly-7-MAD-MDCPT. -
BA2696 PSMA-ALB-56Summary: PSMA-ALB-56 is a PSMA-targeting radioligand. -
BA2697 IM-2Summary: IM-2 is a linker. -
BA2698 DBCO-PEG4-Ahx-DM1Summary: DBCO-PEG4-Ahx-DM1 is an active molecule binding agent consisting of the microtubule protein inhibitor DM1 and the linker DBCO-PEG4-Ahx. -
BA2699 MC-Val-Cit-PAB-RetapamulinSummary: Part of an antibody-coupled active molecule consisting of the protein synthesis inhibitor Retapamulin linked to MC-Val-Cit-PAB. -
BA2700 MC-Val-Cit-PAB-rifabutinSummary: MC-Val-Cit-PAB-rifabutin is part of an antibody-coupled active molecule. -
BA2701 NHS-MMAFSummary: NHS-MMAF is a modified MMAF. -
BA2702 PSMA-Val-Cit-PAB-MMAESummary: PSMA-Val-Cit-PAB-MMAE is a novel small molecule PSMA-targeting conjugate based on MMAE.

